Chun‐Wen Cheng

1.9k total citations
55 papers, 1.6k citations indexed

About

Chun‐Wen Cheng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chun‐Wen Cheng has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Chun‐Wen Cheng's work include Estrogen and related hormone effects (6 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Chun‐Wen Cheng is often cited by papers focused on Estrogen and related hormone effects (6 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Chun‐Wen Cheng collaborates with scholars based in Taiwan, United States and China. Chun‐Wen Cheng's co-authors include Chen‐Yang Shen, Pei‐Ei Wu, Jyh‐Cherng Yu, Yi‐Hsien Hsieh, Chiun‐Sheng Huang, Jia‐Ching Shieh, Yi‐Ping Fu, Hsiao-Wei Wang, Chia‐Liang Lin and Chung‐Tai Yue and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Chun‐Wen Cheng

52 papers receiving 1.6k citations

Peers

Chun‐Wen Cheng
Mustapha Kandouz United States
Myoung Ok Kim South Korea
Samy L. Habib United States
Hyun‐Seok Kim South Korea
Ayoung Kim South Korea
Mustapha Kandouz United States
Chun‐Wen Cheng
Citations per year, relative to Chun‐Wen Cheng Chun‐Wen Cheng (= 1×) peers Mustapha Kandouz

Countries citing papers authored by Chun‐Wen Cheng

Since Specialization
Citations

This map shows the geographic impact of Chun‐Wen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Wen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Wen Cheng more than expected).

Fields of papers citing papers by Chun‐Wen Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Wen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Wen Cheng. The network helps show where Chun‐Wen Cheng may publish in the future.

Co-authorship network of co-authors of Chun‐Wen Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Wen Cheng. A scholar is included among the top collaborators of Chun‐Wen Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Wen Cheng. Chun‐Wen Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, Wen‐Ling, Yu‐Fan Liu, Hairong Liang, et al.. (2025). rFIP‐GMI Suppresses IGF‐1–Induced Invasion and Migration in Breast Cancer Cells via PI3K/Akt/β‐Catenin Inhibition. Drug Development Research. 86(8). e70202–e70202.
2.
Yeh, Jih‐Kai, Victor Chien‐Chia Wu, Shao‐Wei Chen, et al.. (2025). Beyond the infection: mapping the risk of cardiovascular events post-scrub typhus in a nationwide cohort study. Emerging Microbes & Infections. 14(1). 2467766–2467766. 1 indexed citations
3.
Cheng, Chun‐Wen, Yu‐Fan Liu, Wen‐Ling Liao, et al.. (2024). miR-622 Increases miR-30a Expression through Inhibition of Hypoxia-Inducible Factor 1α to Improve Metastasis and Chemoresistance in Human Invasive Breast Cancer Cells. Cancers. 16(3). 657–657. 3 indexed citations
4.
Cheng, Chun‐Wen, et al.. (2023). Purple Sweet Potato Powder Containing Anthocyanin Mitigates High-Fat-Diet-Induced Dry Eye Disease. International Journal of Molecular Sciences. 24(8). 6983–6983. 11 indexed citations
5.
Cheng, Chun‐Wen, et al.. (2020). Fine particulate matter PM2.5 generated by building demolition increases the malignancy of breast cancer MDA-MB-231 cells. Chemosphere. 265. 129028–129028. 15 indexed citations
6.
Lin, Chia‐Liang, Chien-Hsing Lee, Chien‐Min Chen, et al.. (2018). Protodioscin Induces Apoptosis Through ROS-Mediated Endoplasmic Reticulum Stress via the JNK/p38 Activation Pathways in Human Cervical Cancer Cells. Cellular Physiology and Biochemistry. 46(1). 322–334. 88 indexed citations
8.
Chen, Chien‐Min, et al.. (2017). Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1864(10). 1867–1876. 35 indexed citations
9.
Hsieh, Shu-Ching, et al.. (2013). α-Mangostin induces mitochondrial dependent apoptosis in human hepatoma SK-Hep-1 cells through inhibition of p38 MAPK pathway. APOPTOSIS. 18(12). 1548–1560. 48 indexed citations
10.
Shieh, Jia‐Ching, et al.. (2012). Polymorphisms of DNA Repair Pathway Genes and Cigarette Smoking in Relation to Susceptibility to Large Artery Atherosclerotic Stroke among Ethnic Chinese in Taiwan. Journal of Atherosclerosis and Thrombosis. 19(4). 316–325. 21 indexed citations
11.
Cheng, Chun‐Wen, Yu‐Fan Liu, Jyh‐Cherng Yu, et al.. (2012). Prognostic Significance of cyclin D1, β-catenin, and MTA1 in Patients with Invasive Ductal Carcinoma of the Breast. Annals of Surgical Oncology. 19(13). 4129–4139. 30 indexed citations
12.
Yu, Jyh‐Cherng, Chia‐Ni Hsiung, Huan-Ming Hsu, et al.. (2011). Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development. Breast Cancer Research. 13(1). R13–R13. 29 indexed citations
13.
Ding, Shian-ling, Jyh‐Cherng Yu, Shou‐Tung Chen, et al.. (2010). Diverse Associations between ESR1 Polymorphism and Breast Cancer Development and Progression. Clinical Cancer Research. 16(13). 3473–3484. 28 indexed citations
14.
Shieh, Jia‐Ching, et al.. (2010). Association of MTHFR, MTR, and MTRR polymorphisms with Parkinson's disease among ethnic Chinese in Taiwan. Clinica Chimica Acta. 412(3-4). 332–338. 32 indexed citations
15.
Fu, Yi‐Ping, Jia‐Ching Shieh, Jiu‐Haw Yin, et al.. (2010). Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke. Clinica Chimica Acta. 411(11-12). 840–845. 24 indexed citations
16.
Huang, Chiun‐Sheng, Chen‐Yang Shen, Hsiao-Wei Wang, Pei‐Ei Wu, & Chun‐Wen Cheng. (2007). Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer. Clinica Chimica Acta. 384(1-2). 69–74. 41 indexed citations
17.
Cheng, Chun‐Wen, Jyh‐Cherng Yu, Chiun‐Sheng Huang, et al.. (2007). Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Research and Treatment. 111(1). 145–155. 42 indexed citations
18.
Wu, Ruey‐Meei, et al.. (2006). Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease. Clinica Chimica Acta. 378(1-2). 136–141. 78 indexed citations
20.
Chen, Shou‐Tung, Chiun‐Sheng Huang, Yi‐Ping Fu, et al.. (2004). Breast cancer risk associated with genotype polymorphism of the catechol estrogen‐metabolizing genes: A multigenic study on cancer susceptibility. International Journal of Cancer. 113(3). 345–353. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026